SILO PHARMA, INC. (SILO) Return on equity 2020–2025
SILO PHARMA, INC. (SILO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.0%FY2025 · since FY2020: -237.2% → -67.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.0% | +20.2 pp |
| FY2024 | -87.3% | -27.3 pp |
| FY2023 | -59.9% | -22.1 pp |
| FY2022 | -37.8% | — |
| FY2020 | -237.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SILO financial trends
SILO RevenueSILO Net incomeSILO Net marginSILO Gross profitSILO Gross marginSILO Operating incomeSILO Operating marginSILO Operating cash flowSILO Free cash flowSILO Capital expendituresSILO Stock buybacksSILO Dividends paidSILO Total assetsSILO Total liabilitiesSILO Shareholders’ equitySILO overview →